Grading in ovarian cancer

[I] Broders A. C.: "Carcinoma: Grading and practical application". Arch. Pathol., 1926, 2, 376.

[2] Russel P.: "The pathological assessment of ovarian neoplasms, III: The malignant "epithelial" tumours". Pathology, 1979, 11, 493.

[3] Shimizu Y., Kamoi S., Amada S., Akiyama F., Silverberg S. G.: "Toward the development of a universal grading system for ovarian epithelial carcinoma". Cancer, 1998, 82 (5), 893.

[4] Bichel P., Jakobsen A.: "A new histologic grading index in ovarian carcinoma". lnt. J. Gynecol. Pathol., 1989, 8, 147.

[5] Friedlander M. L.,Taylor I. W., Russel P., Musgrove E. A., Hedley D. H., Tattersall M. H.: "Ploidy as a prognostic factor in ovarian cancer". lnt. J. Gynecol. Pathol., 1983, 2 (1), 55.

[6] Rodenburg C. J., Comelisse C. J., Hermans J., Fleuren G. J.: "DNA flow cytometry and morphometry as prognostic indicators in advanced ovarian cancer: a step forward in predicting the clinical outcome". Gynecol. Oncol., 1988; 29 (2): 176.

[7] Haapasalo H., Atkin N. B., Colian Y., Pesonen E., Paljari L.: "Tumour ploidy, morphometry, histological grading and clinical features in ovarian carcinoma: mutual relations". Anal. Cell. Pathol., 1991, 3 (5), 261.

[8] Kuhn W., Feichter G. E., Hanke J., Rummel H. H., Kaufmann M., Schmid H.: "Clinical course of ovarian cancer in relation to morphologic prognostic factors and cell kinetic parameters". Geburtshilfe Frauenheilkd, 1987, 47 (7), 446.

[9] Schonborn I., Minguillon C., Reles A., Bartel U., Lichtenegger W.: "Significance of PCNA proliferating fraction for prognosis of ovarian carcinoma". Geburtshilfe Frauenhilkd, 1996, 56 (7), 357.

[10] Huettner P. C., Weinberg D. S., Lage J.M.: "Assessment of proliferative activity in ovarian neoplasms by flow and static cytometry". Am. J. Path., 1992, 141 (3), 699.

[ 11] Darai E., Walker-Combrouze F., Dauge-Geoffroy M. C., V incent Y., Feldmann G., Madelenat P., Scoazec J. Y:. "Ki-67 expression in 35 borderline ovarian tumors: relation with clinicopathologic parameters and ploidy". Eur. J. Obstet. Gynecol. Reprod. Biol., 1998, 76 (2), 175.

[12] Jordan P. A., Kerns B. J., Pence J. C., Kohler H. F.. Bast R. C. Jr.. Kinney R. B., Berchuck A.: "Determination of proliferation index in advanced ovarian cancer using quantitative image analysis". Am. J. Clin. Pathol., 1993, 99 (6), 736

[13] Gazzetti G. G., Ciavattini A., Goteri G., DeNictolis M., Stramazzotti D., Lucarini G., Biagini G.: "Ki-67 antigen immunostaining (MIBI monoclonal antibody) in serous ovarian tumors: index of proliferative activity with prognostic significance". Gynecol. Oneal., 1995, 56 (2), 169

[14] Kerns B. J., Jordan P. A., Faerman L. L., Berchuck A.. Bast R. C. Jr., Layfield L. J.: "Determination of proliferation index with MIB-1 in advanced ovarian cancer using quantitative image analysis". Am. J. Clin. Pathol., 1994, 101 (2), 192.

[15] Marx D., Meden H., Brune T.. Kron M., Korabiowska M., Kuhn W., Schauer A.: "MIB-1 evaluated proliferative activity m ovarian cancer with respect to prognostic significance". Anticance1: Res., 1997, 17 (1 B), 775.

[16] Ghazizadeh H., Sasaki G., Araki T., Konishi H.. Aihara K.: "Prognostic value of proliferative activity of ovarian carcinoma as revealed by PCNA and AgNOR analyses". Am. J. Clin. Pathol., 1997, Apr., 107 (4), 451.

[17] Griffiths A. P., Cross D., Knigston R. E., Harkin P., Wells M., Quirke P.: "Flow cytometry and AgNORs in benign, borderline, and malignant mucinous and serous tumours of the ovary". Int. J. Gynecol. Pathol., 1993, 12 (4), 307.

[18] Albrecht M., Goepel E., Simon W. E., Trams G.: "Importance of clinically prognostic factors in the treatment of advanced ovarian carcinoma". Gebirtshiife Frauenheilkd, 1985. 45 (7). 482.

[19] Lotze W., Richter P.. Sarembe B.: "Intra-arterial chemotherapy in advanced ovarian cancer. I Study conditions and prognostic factors" Zentralbl. Gynakol., 1987, 109 (7), 443.

[20] Malkasian G.D. Jr.. Melton L. J., O'Brien P. C., Green M. H.: "Prognostic significance of histologic classification and grading of epithelial malignancies of the ovary•·. Am. J. Obstet. Gynecol., 1984, 149, 274.

[21] Haapasalo H., Colian Y., Seppa A., Gidlund A. L., Atkin N. B.. Pesonen E.: "Prognostic value of ovarian carcinoma grading methods -a method comparison study". Histopathology, 1990, 16 (1), I.

[22] Baak J.P., Langley F. A.. Talerman A., Delemarre J. F.: "The prognostic variability of ovarian tumor grading by different pathologists" Gynecol. Oneal., 1987, 27 (2), 166.

[23] Frigerio L., Ferrari A., Busci L., Pirondini A., Garsia S.. Caldarella M.. Pifarotti G.: "Prognosis factors in epithelial tumors of the ovary" Ann. Ostet. Ginecol. Med. Perinal., 1989, 110 (6)., 283.

[24] Gargano G., Catino A., Correale M., Lorusso V., Abbate I., Izzi G., Cramarossa A., et al.: "Prognostic factors in epithelial ovanan cancer". Eur. J. Gynaecol. Oncol., 1992, 13 (I Suppl)., 45.

[25] Kaufmann M., Heberling D., Hoeffken H., Markel S.: "Therapy in metastsizing ovarian cancer-survival rate correlated with histological and cytological grading as prognostic factors". Geburtshiife Frauenheilkd, 1983, 43 (1), 15.

[26] Levin L., Lund B、Heintz A. P.: "Advanced ovarian cancer. An overview of multi-variate analyses of prognostic variables with special reference to the role of cytoreductive surgery". Ann. Oncol., 1993, 4 (Suppl. 4), 23.

[27] Sasaki H., Ochiai K., Terashima Y.. Mochizuki S., Soda T., Nishimura H., Yakushiji M., Hirabayashi M.: "Prognostic factors of common epithelial ovarian cancer treated by surgery and cisplatin based combination chemotherapy". Gan. No. Rinsho., 1989, 35 (13), 1615.

[28] Shulz B. O., Baker E., Strolz C., Sellin D., Stegner H. E., Krebs D.: "Grading of epithelial ovarian cancer". Geburtsh. Frauenhilkd, 1985. 45 (I)., 11.

[29] Stegner H. E.: "Morphological prognosis factors in ovarian carcinoma". Geburtshilje Frauenheilkd, 1985, 45 (7), 425.

[30] Vacher-Lavenu M. C., Le Tourneau A., Duvillard P., Godefroy N., Pinel M. C.: "Pathological classification and grading of pnmary ovarian carcinoma: experience of the ARTAC ovarian study group". Bull. Cancer, 1993, 80 (2), 135.

[31] Baak J.P., Wisse-Brekelmans E. C.. Langlay F. A., Talerman A., Delemarre J. F.: "Morphometric data to FIGO stage and histological type and grade for prognosis of ovarian tumours". J. Clin. Pathol., 1986, 39 (I 2), 1340.

[32] Haapsalo H., Pesonen E., Colian Y.: "Volume corrected mitotic index ( M/V-INDEX). The standard of mitotic activity in neoplasms" Path. Res. Pract., 1989, 185. 551.

[33] Powlis W. D., Mauch P., Ehrmann R. L., Rose C. M., Knapp R. C., Bloomer W. D.:'The role of postoperative local or regional irradiation in the treatment of stage I ovarian cancer". Radiology, 1982, 142 (3), 747.

[34] Oliva E., Andrada E., Pezzica E., Prat J.: ·•ovarian carcinoma with choriocarcinomatous differentiation". Cancer, 1993, 72 (8), 2441.

[35] Hanahan D., Weinberg A.:'The hallmarks of cancer". Cell., 2000, 100, 57.